Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.30 EUR | +8.46% |
|
+8.05% | +8.74% |
Mar. 14 | DERMAPHARM : Receives a Buy rating from Jefferies | ZD |
Mar. 14 | Dermapharm Expects Consolidated Revenue Of Between Eur 1.1 Bln And Eur 1.2 Bln In 2025 | RE |
Chart calendar Dermapharm Holding SE
Upcoming events on Dermapharm Holding SE
Past events on Dermapharm Holding SE
2025-03-14 02:30 am | Q4 2024 Earnings Release |
2024-11-24 | German Equity Forum |
2024-11-14 01:30 am | Q3 2024 Earnings Release |
2024-08-27 01:30 am | Q2 2024 Earnings Release |
2024-08-26 | Q2 2024 Earnings Call |
2024-06-26 | Annual General Meeting |
2024-05-15 01:30 am | Q1 2024 Earnings Release |
2024-05-14 | Q1 2024 Earnings Call |
2024-03-28 02:30 am | Q4 2023 Earnings Release |
2024-03-27 | Q4 2023 Earnings Call |
2023-11-15 01:30 am | Q3 2023 Earnings Release |
2023-11-14 | Q3 2023 Earnings Call |
2023-08-29 01:30 am | Q2 2023 Earnings Release |
2023-08-28 | Q2 2023 Earnings Call |
2023-06-13 | Annual General Meeting |
2023-05-14 | Q1 2023 Earnings Release |
2023-03-27 | Q4 2022 Earnings Call |
2023-03-27 | Q4 2022 Earnings Release |
2023-03-12 | Berenberg EU Opportunities Conference |
2022-12-04 | Berenberg European Conference |
Past dividends on Dermapharm Holding SE
2024-06-27 | Annual 0.88 EUR |
2023-06-14 | Annual 1.05 EUR |
2022-06-01 | Annual 2.17 EUR |
2021-06-23 | Annual 0.88 EUR |
2020-06-17 | Other Dividend 0.8 EUR |
2019-06-04 | Other Dividend 0.77 EUR |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 943 944 -0.13% | 1 025 1 038 -1.28% | 1 135 1 125 0.91% | 1 168 | 1 211 | 1 266 |
EBITDA Million EUR | Released Forecast Spread | 351 348 0.76% | 360 360 -0.13% | 310 299 3.82% | 311 | 333 | 348 |
EBIT Million EUR | Released Forecast Spread | 298 295 1.29% | 244 284 -14.16% | 183 203 -9.68% | 214 | 237 | 247 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 293 288 1.75% | 216 274 -21.03% | 106 139 -23.7% | 168 | 191 | 200 |
Net income Million EUR | Released Forecast Spread | 210 204 2.81% | 134 193 -30.51% | 62,4 110 -43.14% | 113 | 134 | 142 |
EPS EUR | Released Forecast Spread | 3,89 3,79 2.71% | 2,49 3,58 -30.49% | 1,16 2,04 -43.07% | 2,10 | 2,49 | 2,64 |
Announcement Date | 12/04/22 | 28/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 319 289 10.42% | 263 260 1.15% | 582 581 0.19% | 269 291 -7.53% | 299 280 6.68% | 295 | |||
EBITDA Million EUR | Released Forecast Spread | 106 91,1 16.2% | 62,2 62,0 0.32% | 168 164 2.44% | 66,4 74,0 -10.27% | 88,7 76,2 16.4% | 87,3 73,0 19.59% | 74,2 | ||
Net income Million EUR | Released Forecast Spread | 49,1 36,7 33.78% | 24,8 | 17,3 | ||||||
EPS EUR | Released Forecast Spread | 0,46 | 0,32 | |||||||
Announcement Date | 15/05/23 | 29/08/23 | 29/08/23 | 16/11/23 | 28/03/24 | 15/05/24 | 27/08/24 | - | - |
Past sector events for Dermapharm Holding SE
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DMP Stock
- Calendar Dermapharm Holding SE